Main public logs
Combined display of all available logs of Compendium of Cancer Genome Aberrations. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).
- 03:22, 26 May 2021 127.0.0.1 talk set 8088 as the approved revision for "Myeloid/Lymphoid Neoplasms with Eosinophilia and Gene Rearrangement"
- 03:22, 26 May 2021 127.0.0.1 talk set 8089 as the approved revision for "Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2"
- 03:22, 26 May 2021 127.0.0.1 talk set 8084 as the approved revision for "Editing Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2"
- 03:22, 26 May 2021 127.0.0.1 talk set 8279 as the approved revision for "Myeloid/Lymphoid Neoplasms with BCR-JAK2"
- 03:22, 26 May 2021 127.0.0.1 talk set 8280 as the approved revision for "Myeloid/Lymphoid Neoplasms with ETV6-JAK2"
- 03:22, 26 May 2021 127.0.0.1 talk set 7996 as the approved revision for "B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements"
- 03:22, 26 May 2021 127.0.0.1 talk set 9988 as the approved revision for "Leadership"
- 03:22, 26 May 2021 127.0.0.1 talk set 7900 as the approved revision for "Erdheim-Chester Disease"
- 03:22, 26 May 2021 127.0.0.1 talk set 7910 as the approved revision for "Disseminated Juvenile Xanthogranuloma"
- 03:22, 26 May 2021 127.0.0.1 talk set 7909 as the approved revision for "Fibroblastic Reticular Cell Tumor"
- 03:22, 26 May 2021 127.0.0.1 talk set 7908 as the approved revision for "Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma"
- 03:22, 26 May 2021 127.0.0.1 talk set 9903 as the approved revision for "Follicular Dendritic Cell Sarcoma"
- 03:22, 26 May 2021 127.0.0.1 talk set 7906 as the approved revision for "Interdigitating Dendritic Cell Sarcoma"
- 03:22, 26 May 2021 127.0.0.1 talk set 7905 as the approved revision for "Indeterminate Dendritic Cell Tumour"
- 03:22, 26 May 2021 127.0.0.1 talk set 7904 as the approved revision for "Langerhans Cell Sarcoma"
- 03:22, 26 May 2021 127.0.0.1 talk set 7903 as the approved revision for "Langerhans Cell Histiocytosis"
- 03:22, 26 May 2021 127.0.0.1 talk set 9902 as the approved revision for "Tumors Derived From Langerhans Cells"
- 03:22, 26 May 2021 127.0.0.1 talk set 7901 as the approved revision for "Histiocytic Sarcoma"
- 03:22, 26 May 2021 127.0.0.1 talk set 9901 as the approved revision for "Histiocytic and Dendritic Cell Neoplasms"
- 03:22, 26 May 2021 127.0.0.1 talk set 7897 as the approved revision for "Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders"
- 03:22, 26 May 2021 127.0.0.1 talk set 7896 as the approved revision for "Classical Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder"
- 03:22, 26 May 2021 127.0.0.1 talk set 7895 as the approved revision for "Monomorphic T/NK-cell PTLD"
- 03:22, 26 May 2021 127.0.0.1 talk set 7894 as the approved revision for "Monomorphic B-cell PTLD"
- 03:22, 26 May 2021 127.0.0.1 talk set 7893 as the approved revision for "Monomorphic Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)"
- 03:22, 26 May 2021 127.0.0.1 talk set 7892 as the approved revision for "Polymorphic Post-Transplant Lymphoproliferative Disorders"
- 03:22, 26 May 2021 127.0.0.1 talk set 7891 as the approved revision for "Non-Destructive Post-Transplant Lymphoproliferative Disorders"
- 03:22, 26 May 2021 127.0.0.1 talk set 9900 as the approved revision for "Post-Transplant Lymphoproliferative Disorders"
- 03:22, 26 May 2021 127.0.0.1 talk set 7889 as the approved revision for "Lymphomas Associated with HIV Infection"
- 03:22, 26 May 2021 127.0.0.1 talk set 7574 as the approved revision for "Lymphoproliferative Diseases Associated with Primary Immune Disorders"
- 03:22, 26 May 2021 127.0.0.1 talk set 7571 as the approved revision for "PTLD"
- 03:22, 26 May 2021 127.0.0.1 talk set 9899 as the approved revision for "Immunodeficiency-Associated Lymphoproliferative Disorders"
- 03:22, 26 May 2021 127.0.0.1 talk set 7887 as the approved revision for "Lymphocyte-Depleted Classic Hodgkin Lymphoma"
- 03:22, 26 May 2021 127.0.0.1 talk set 7886 as the approved revision for "Mixed Cellularity Classic Hodgkin Lymphoma"
- 03:22, 26 May 2021 127.0.0.1 talk set 7885 as the approved revision for "Lymphocyte-Rich Classic Hodgkin Lymphoma"
- 03:22, 26 May 2021 127.0.0.1 talk set 7884 as the approved revision for "Nodular Sclerosis Classic Hodgkin Lymphoma"
- 03:22, 26 May 2021 127.0.0.1 talk set 9898 as the approved revision for "Classic Hodgkin Lymphoma"
- 03:22, 26 May 2021 127.0.0.1 talk set 7882 as the approved revision for "Nodular Lymphocyte Predominant Hodgkin Lymphoma"
- 03:22, 26 May 2021 127.0.0.1 talk set 9897 as the approved revision for "Hodgkin Lymphomas"
- 03:22, 26 May 2021 127.0.0.1 talk set 8862 as the approved revision for "Breast Implant-Associated Anaplastic Large Cell Lymphoma"
- 03:22, 26 May 2021 127.0.0.1 talk set 9576 as the approved revision for "Anaplastic Large Cell Lymphoma, ALK-Negative"
- 03:22, 26 May 2021 127.0.0.1 talk set 9573 as the approved revision for "Anaplastic Large Cell Lymphoma, ALK-Positive"
- 03:22, 26 May 2021 127.0.0.1 talk set 9619 as the approved revision for "Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype"
- 03:22, 26 May 2021 127.0.0.1 talk set 7876 as the approved revision for "Follicular T-cell Lymphoma"
- 03:22, 26 May 2021 127.0.0.1 talk set 9896 as the approved revision for "Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin"
- 03:22, 26 May 2021 127.0.0.1 talk set 7873 as the approved revision for "Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)"
- 03:22, 26 May 2021 127.0.0.1 talk set 7872 as the approved revision for "Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder"
- 03:22, 26 May 2021 127.0.0.1 talk set 7871 as the approved revision for "Primary Cutaneous Acral CD8+ T-cell Lymphoma"
- 03:22, 26 May 2021 127.0.0.1 talk set 7870 as the approved revision for "Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma"
- 03:22, 26 May 2021 127.0.0.1 talk set 7869 as the approved revision for "Primary Cutaneous Gamma Delta T-cell Lymphoma"
- 03:22, 26 May 2021 127.0.0.1 talk set 9895 as the approved revision for "Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes"